GSK3B and Alzheimer disease: Studies by Nicolia et al. [117] in neuroblastoma cells, analyzing hypomethylation in postmortem frontal cortex, showed that patients with initial AD present inactive GSK3β decreases, whereas patients in the pathological stage V-VI level present large increases in inactive GSK3β.